Update on inhalational anaesthetics

Current Opinion in Anaesthesiology

Volumn 22, Issue 4, 2009, Pages 491-495

  De Hert, Stefan G ^a   Preckel, Benedikt ^a   Schlack, Wolfgang S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Inhalational anaesthetics; Noble gases; Organ function

Indexed keywords

AMINOTRANSFERASE; CASPASE 3; CREATINE KINASE MB; CREATININE; DESFLURANE; HALOTHANE; ISOFLURANE; MIDAZOLAM; PROPOFOL; REMIFENTANIL; SEVOFLURANE; TROPONIN T; XENON;

AGITATION; AIRWAY RESISTANCE; AMINOTRANSFERASE BLOOD LEVEL; ANESTHETIC RECOVERY; AORTA SURGERY; APOPTOSIS; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG DEGRADATION; DRUG EXPOSURE; DRUG MECHANISM; DRUG METABOLISM; ENZYME BLOOD LEVEL; HEART AFTERLOAD; HEART PROTECTION; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INCIDENCE; ISCHEMIA; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; LIVER SURGERY; MORTALITY; MYOCARDIAL DISEASE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; OFF PUMP CORONARY SURGERY; ORGAN PERFUSION; ORGAN PROTECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTECTION; REPERFUSION INJURY; REVIEW; RISK; SAFETY; SEDATION; SIDE EFFECT; SUBSTANCE ABUSE; TREATMENT OUTCOME; VASCULAR SURGERY;

ANESTHETICS, INHALATION; ANIMALS; HEART; HUMANS; INTENSIVE CARE UNITS; MYOCARDIAL REPERFUSION INJURY; XENON;

EID: 68949092051     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32832bca38     Document Type: Review

References (56)

1. Terrell RC. The invention and development of enflurane, isoflurane, sevoflurane, and desflurane. Anesthesiology 2008; 108:531-533.
2. Wei H, Liang G, Yang H, et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-triphosphate receptors. Anesthesiology 2008; 108:251-260.
3. Mio Y, Bienengraber MW, Marinovic J, et al. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochon-drial respiration and sarcolemmal adenosine triphosphate sensitive potassium channel activity. Anesthesiology 2008; 108:612-620.
4. Lange M, Smul TM, Redel A, et al. Differential role of calcium/calmodulin-dependent protein kinase II in desflurane-induced preconditioning and cardioprotection by metoprolol: metoprolol blocks desflurane-induced preconditioning. Anesthesiology 2008; 109:72-80.
5. Lemoine S, Beauchef G, Zhu L, et al. Signaling pathways involved in desflurane-induced postconditioning in human atrial myocardium in vitro. Anesthesiology 2008; 109:1036-1044.
6. Kaneda K, Miyamae M, Sugioka S, et al. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial Katp channels, and nitric oxide synthase, in guinea pig hearts. Anesth Analg 2008; 106:9-16.
7. Riess ML, Costa AD, Carlson R Jr, etal. Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria. Anesth Analg 2008; 106:1049-1055.
8. Kitahata H, Nozaki J, Kawahito S, et al. Low-dose sevoflurane inhalation enhances late cardioprotection from the ant-ulcer drug geranylgeranylace-tone. Anesth Analg 2008; 107:755-761.
9. Huhn R, Heinen A, Weber NC, et al. Hyperglycemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 2008; 100:465-471.
10. Feng J, Zhu M, Schaub MC, et al. Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide trans-locator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 2008; 80:20-29.
11. Li H, Wang JK, Zeng YM, etal. Sevoflurane postconditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3- kinase signal transduction. Clin Exp Pharmacol Physiol 2008; 35:1043-1051.
12. Weber NC, Goletz C, Huhn R, et al. Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases. Eur J Pharmacol 2008; 592:48-54.
13. Chen CH, Chuang JH, Liu K, Chan JY. Nitric oxide triggers delayed anesthetic preconditioning-induced cardiac protection via activation of nuclear factor kappa B and upregulation of inducible nitric oxide synthase. Shock 2008; 30:241-249.
14. Weber NC, Schlack W. Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol 2008; 182:187-207.
15. Pagel PS. Postconditioning by volatile anesthetics: salvaging ischemic myocardium at reperfusion by activation of prosurvival signalling. J Cardiothorac Vasc Anesth 2008; 22:753-765.
16. Bein B, Renner J, Caliebe D, et al. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardiopulmonary bypass in coronary artery surgery: comparison with continuous propofol. Anaesthesia 2008; 63:1046-1055.
17. Cromheecke S, Pepermans V, Hendrickx E, etal. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006; 103:289-296.
18. Landoni G, Calabro MG, Marchetti C, et al. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007; 21:672-677.
19. De Hert SG, Longrois D, Yang H, Fleisher LA. Does the use of a volatile anesthetic regimen reduce the incidence of cardiac events after cardiac surgery. Acta Anaesthesiol Belg 2008; 59:19-25.
20. Landoni G, Zangrillo A, Fochi O, et al. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth 2008; 22:543-547.
21. Kim M, Kim M, Kim N, etal. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate- dependent pathways. Am J Physiol Renal Physiol 2007; 293:F1827-F1835.
22. Lee HT, Chen SW, Doetschman TC, et al. Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta 1 pathway. Am J Physiol Renal Physiol 2008; 295:F128-F136.
23. Lee HT, Emala CW, Joo JD, Kim M. Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis. Shock 2007; 27:373-379.
24. Bedirli N, Ofluoglu E, Kerem M, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg 2008; 106:830-837.
25. Schmidt R, Tritschler E, Hoetzel A, et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfu-sion injury. Ann Surg 2007; 245:931-942.
26. Yue T, Roth Z'graggen B, Blumenthal S, et al. Postconditioning with a volatile anesthetic in alveolar epithelial cells in vitro. Eur Respir J 2008; 31:118-125.
27. Kalb R, Schober P, Schwarte LA, et al. Preconditioning but not postconditioning with sevoflurane reduces pulmonary neutrophil accumulation after lower body ischaemia/reperfusion injury in rats. Eur J Anaesthesiol 2008; 25:454-459.
28. Steurer M, Schlapfer M, Steurer M, et al. The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages. Clin Exp Immunol 2009; 155:224-230.
29. Zhao P, Peng L, Li L, et al. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 2007; 107:963-970.
30. Xu X, Kim JA, Zuo Z. Isoflurane preconditioning reduces mouse microglial activation and injury induced by lipopolysaccharide and interferon-gamma. Neuroscience 2008; 154:1002-1008.
31. Matsumoto S, Murozono M, Nagaoka D, etal. Isoflurane inhibits protein kinase C gamma and calcium/calmodulin dependent protein kinase II-alpha translo-cation to synaptic membranes in ischemic mice brains. Neurochem Res 2008; 33:2302-2309.
32. Luo Y, Ma D, Ieong E, etal. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008; 109:782-789.
33. Teixeira S, Costa G, Costa F, et al. Sevoflurane versus isoflurane: does it matter in renal transplantation? Transplant Proc 2007; 39:2486-2488.
34. Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248:909-918.
35. Ko JS, Gwak MS, Choi SJ, et al. The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepa-tectomy in liver donors. Liver Transpl 2008; 14:1150-1158.
36. Preckel B, Weber NC, Sanders RD, etal. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006; 105:187-197.
37. Ruzicka J, Benes J, Bolek L, Markvartova V. Biological effects of noble gases. Physiol Res 2007; 56 (Suppl 1):S39-S44.
38. Derwall M, Coburn M, Rex S, et al. Xenon: recent developments and future perspectives. Minerva Anesthesiol 2008; 74:1-9.
39. Harris PD, Barnes R. The uses of helium and xenon in current clinical practice. Anaesthesia 2008; 63:284-293.
40. Hein M, Baumert JH, Roehl AB, et al. Xenon alters right ventricular function. Acta Anaesthesiol Scand 2008; 52:1056-1063.
41. Baumert JH, Hein M, Hecker KE, et al. Xenon or propofol anaesthesia for patients at cardiovascular risk in noncardiac surgery. Br J Anaesth 2008; 100:605-611.
42. Weber NC, Frässdorf J, Ratajczak C, et al. Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2? Anesth Analg 2008; 107:1807-1813.
43. Weber NC, Kandler J, Schlack W, et al. Intermitted pharmacological pre-treatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor a-induced adhesion molecule expression in human umbilical vein endothelial cells. Anesthesiology 2008; 108:199-207.
44. Cattano D, Williamson P, Fukui K, et al. Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can J Anaesth 2008; 55:429-436.
45. Pagel PS, Krolikowski JG, Shim YH, et al. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signalling kinases and inhibiting mitochondrial permeability transition pore in vivo. Anesth Analg 2007; 105:562-569.
46. Pagel PS, Krolikowski JG, Pratt PF Jr, et al. The mechanisms of helium-induced preconditioning: a direct role for nitric oxide in rabbits. Anesth Analg 2008; 107:762-768.
47. Pagel PS, Krolikowski JG, Pratt PF Jr, et al. Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardio-protection in vivo: the role of mitochondrial permeability transition. Anesth Analg 2008; 107:769-775.
48. Pagel PS, Krolikowski JG, Pratt PF Jr, et al. Reactive oxygen species and mitochondrial adenosine triphosphate-regulated potassium channels mediate helium-induced preconditioning against myocardial infarction in vivo. J Cardiothorac Vasc Anesth 2008; 22:554-559.
49. 2+ sensitive potassium channel activation. Anesthesiology 2008; 109:830-836.
50. Röhm KD, Wolf MW, Schöllhorn T, et al. Short-term sevoflurane sedation using the anaesthetic conserving device after cardiothoracic surgery. Intensive Care Med 2008; 34:1683-1689.
51. Tobias JD. Therapeutic applications and uses of inhalational anesthesia in the pediatric intensive care unit. Pediatr Crit Care Med 2008; 9:169-179.
52. Kuratani N, Oi Y. Greater incidence of emergence agitation in children after sevoflurane anesthesia as compared with halothane. Anesthesiology 2008; 109:225-232.
53. von Ungern-Sternberg BS, Saudan S, Petak F, et al. Desflurane but not sevoflurane impairs airway and respiratory tissue mechanics in children with susceptible airways. Anesthesiology 2008; 108:216-224.
54. Kharash ED. Adverse drug reactions with halogenated anesthetics. Clin Pharmacol Ther 2008; 84:158-162.
55. Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children. Anesth Analg 2007; 104:509-520.
56. Wilson JE, Kiselanova N, Stevens Q, et al. A survey of inhalational anaesthetic abuse in anaesthesia training programmes. Anaesthesia 2008; 63:616-620.